Eduard Schering

Eduard Schering was a renowned German pharmacist and entrepreneur, best known for founding the pharmaceutical company Schering AG in Berlin in 1871, which later became part of Bayer. He was a prominent figure in the development of the German pharmaceutical industry, working closely with other notable pharmacists, including Friedrich Bayer and Johann Friedrich Wilhelm Adolf von Baeyer. Schering's contributions to the field of pharmacy were recognized by his peers, including Robert Koch and Emil von Behring, and he played a significant role in the establishment of the University of Berlin's pharmacy program. His work was also influenced by the research of Louis Pasteur and Robert Bunsen.

● Early Life and Education

Eduard Schering was born in Dresden to a family of Saxon pharmacists, including his father, Heinrich Schering, who owned a pharmacy in the city. He studied pharmacy at the University of Leipzig under the guidance of Hermann Kolbe and Wilhelm Ostwald, and later at the University of Berlin under the supervision of August Wilhelm von Hofmann. During his studies, Schering was exposed to the works of prominent scientists, including Justus von Liebig and Friedrich Wöhler, which had a significant impact on his future career. He also worked at the Charité hospital in Berlin, where he met other notable figures, such as Rudolf Virchow and Emil von Behring.

● Career

Schering began his career as a pharmacist in Berlin, working at various pharmacies, including the one owned by Friedrich Bayer. In 1871, he founded his own company, Schering AG, which quickly gained a reputation for producing high-quality pharmaceuticals. Schering's company collaborated with other notable pharmaceutical companies, including Merck KGaA and Boehringer Ingelheim, to develop new products and technologies. He also worked closely with researchers at the Kaiser Wilhelm Institute and the University of Berlin to develop new treatments for various diseases, including those caused by Klebsiella pneumoniae and Streptococcus pyogenes. Schering's company was also involved in the production of aspirin, which was first developed by Felix Hoffmann at Bayer.

● Pharmaceutical Contributions

Eduard Schering made significant contributions to the development of the pharmaceutical industry, including the introduction of new production methods and the development of new products, such as testosterone and estradiol. His company, Schering AG, was one of the first to produce insulin and vaccines on a large scale, working closely with researchers at the University of Toronto and the Institut Pasteur. Schering also collaborated with other notable pharmaceutical companies, including Pfizer and GlaxoSmithKline, to develop new treatments for various diseases, including tuberculosis and malaria. His work was influenced by the research of Alexander Fleming and Selman Waksman, and he played a significant role in the development of antibiotics and vaccines.

● Legacy

Eduard Schering's legacy is still felt today, with his company, Schering AG, continuing to play a major role in the pharmaceutical industry. The company has undergone several mergers and acquisitions, including a merger with Bayer in 2006, and is now part of the Bayer group. Schering's contributions to the development of the pharmaceutical industry have been recognized by numerous awards, including the German Federal Cross of Merit and the Order of the Red Eagle. His work has also been recognized by the American Pharmaceutical Association and the Royal Pharmaceutical Society. Schering's legacy continues to inspire new generations of pharmacists and researchers, including those working at the National Institutes of Health and the World Health Organization. His company's products have had a significant impact on the treatment of various diseases, including cancer and HIV/AIDS, and have improved the lives of millions of people around the world, including those in Africa and Asia.